Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-14

FDA Approved: LACTULOSE — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved an original application for lactulose as a generic drug, manufactured by PAI Holdings (dba PAI Pharma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LACTULOSE (Lactulose)

Snippet

ORIG AP for LACTULOSE (LACTULOSE)